Dunlop C E, Brady B M, McLaughlin M, Telfer E E, White J, Cowie F, Zahra S, Wallace W H B, Anderson R A
Simpson's Centre for Reproductive Health, Royal Infirmary of Edinburgh, Edinburgh, EH16 4SA, UK.
MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, EH16 4TJ, UK.
J Assist Reprod Genet. 2016 Dec;33(12):1615-1620. doi: 10.1007/s10815-016-0805-2. Epub 2016 Sep 17.
With the improvement of long-term cancer survival rates, growing numbers of female survivors are suffering from treatment-related premature ovarian insufficiency (POI). Although pre-treatment embryo and oocyte storage are effective fertility preservation strategies, they are not possible for pre-pubertal girls or women who cannot delay treatment. In these cases, the only available treatment option is ovarian cortex cryopreservation and subsequent re-implantation. A 32-year-old woman had ovarian cortex cryopreserved 10 years previously before commencing high-dose chemotherapy and undergoing a haematopoietic stem cell transplant for recurrent adult Wilms tumour, which resulted in POI. She underwent laparoscopic orthotopic transplantation of cryopreserved ovarian cortex to the original site of biopsy on the left ovary. She ovulated at 15 and 29 weeks post-re-implantation with AMH detectable, then rising, from 21 weeks, and conceived naturally following the second ovulation. The pregnancy was uncomplicated and a healthy male infant was born by elective Caesarean section at 36 weeks gestation. This is the first report of ovarian cortex re-implantation in the UK. Despite the patient receiving low-risk chemotherapy prior to cryopreservation and the prolonged tissue storage duration, the re-implantation resulted in rapid restoration of ovarian function and natural conception with successful pregnancy.
随着癌症长期生存率的提高,越来越多的女性幸存者正遭受与治疗相关的卵巢早衰(POI)。尽管治疗前胚胎和卵母细胞冷冻保存是有效的生育力保存策略,但对于青春期前女孩或无法推迟治疗的女性来说并不适用。在这些情况下,唯一可用的治疗选择是卵巢皮质冷冻保存及随后的再植入。一名32岁女性在开始高剂量化疗并接受复发性成人肾母细胞瘤的造血干细胞移植(该移植导致了POI)之前10年,进行了卵巢皮质冷冻保存。她接受了腹腔镜下将冷冻保存的卵巢皮质原位移植到左卵巢活检的原部位。再植入后15周和29周时她排卵,抗缪勒管激素(AMH)在21周时可检测到且随后上升,第二次排卵后自然受孕。妊娠过程顺利,在妊娠36周时通过择期剖宫产分娩出一名健康男婴。这是英国首例卵巢皮质再植入的报告。尽管患者在冷冻保存前接受了低风险化疗且组织保存时间较长,但再植入仍使卵巢功能迅速恢复并自然受孕且妊娠成功。